Green Leaf Pharmaceuticals (02186.HK) subsidiary plans to issue $150 million in exchangeable preferred shares.

Wisdom Financial News App, Green Leaf Pharmaceuticals (02186.HK) announced that on November 21, 2025, the issuer (a wholly-owned subsidiary of our company), our company and the subscriber entered into a subscription agreement. The subscriber agreed to subscribe and the issuer agreed to issue and issue convertible preferred shares at a total subscription price of 150 million US dollars. These convertible preferred shares can be exchanged for Borg Anne Biotechnology shares in accordance with the terms of the subscription agreement.